Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M58.3Revenue (TTM) $M57.4Net Margin (%)-89.9Altman Z-Score-47.8
Enterprise Value $M26.8EPS (TTM) $-1.9Operating Margin %-84.9Piotroski F-Score4
P/E(ttm)--Beneish M-Score1.5Pre-tax Margin (%)-91.5Higher ROA y-yY
Price/Book4.310-y EBITDA Growth Rate %-55.9Quick Ratio1.3Cash flow > EarningsN
Price/Sales1.05-y EBITDA Growth Rate %-29.2Current Ratio1.4Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-50.9Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-139.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M28.2ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with CTIC

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

CTIC is held by these investors:



CTIC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BIANCO JAMES APresident and CEO 2016-06-24Sell1,000$3.713.24view
BIANCO JAMES APresident and CEO 2016-05-27Sell1,000$4.5-6.89view
BIANCO JAMES APresident and CEO 2016-04-29Sell1,000$5.2-19.42view
BIANCO JAMES APresident and CEO 2016-03-28Sell1,000$4.9-14.49view
BIANCO JAMES APresident and CEO 2016-03-21Sell31,817$5.5-23.82view
Plunkett MatthewEVP, Chief Business Officer 2016-03-04Sell1,000$5.9-28.98view
BIANCO JAMES APresident and CEO 2016-02-26Sell1,000$6.3-33.49view
SINGER JACK WEVP, Chief Scientific Officer 2016-02-26Sell1,500$6.3-33.49view
BIANCO JAMES APresident and CEO 2016-02-16Sell10,000$4.2-0.24view
Plunkett MatthewEVP, Chief Business Officer 2016-02-04Sell1,000$11.5-63.57view

Press Releases about CTIC :

Quarterly/Annual Reports about CTIC:

News about CTIC:

Articles On GuruFocus.com
CTI BioPharma to Report First Quarter 2017 Financial Results on May 3, 2017 Apr 26 2017 
Servier and CTI BioPharma Expand License and Collaboration Agreement to Develop and Commercialize PI Apr 25 2017 
Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against CTI BioPharma Corp. Feb 16 2016 
Monday Morning Pre-Market Insights: Celldex Therapeutics, Celladon Corp, CTI BioPharma Corp, TG Ther Jun 01 2015 
Weekly CEO Sells Highlight: Groupon Inc., Cell Therapeutics Inc., Standard Pacific Corp and Dollar G Mar 24 2014 
These 4 Biotech Stocks Are a Buy Now Feb 08 2012 
Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 50,000 Shares Feb 25 2011 
Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 50,000 Shares Jan 28 2011 
Weekly CEO Sells Highlight: CTIC, DDR, UNM, BRCM, TC Jan 09 2011 
Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 250,000 Shares Jan 03 2011 

More From Other Websites
CTI BioPharma to Report First Quarter 2017 Financial Results on May 3, 2017 Apr 26 2017
ETFs with exposure to CTI BioPharma Corp. : April 26, 2017 Apr 26 2017
Servier and CTI BioPharma Expand License and Collaboration Agreement to Develop and Commercialize... Apr 25 2017
Edited Transcript of CTIC earnings conference call or presentation 2-Mar-17 9:30pm GMT Mar 31 2017
ETFs with exposure to CTI BioPharma Corp. : March 30, 2017 Mar 29 2017
CTI BioPharma Corp. :CTIC-US: Earnings Analysis: Q4, 2016 By the Numbers : March 16, 2017 Mar 16 2017
CTI BioPharma to Present at the 29th Annual ROTH Conference Mar 08 2017
CTI BioPharma reports 4Q loss Mar 02 2017
CTI BioPharma Reports Fourth Quarter and Full Year 2016 Financial Results Mar 02 2017
CTI BioPharma hires new CEO Mar 01 2017
CTI BioPharma Announces Appointment of Hematology/Oncology Clinical Expert Adam Craig, M.D., Ph.D.,... Feb 27 2017
CTI BioPharma to Report Fourth Quarter and Full Year 2016 Financial Results on March 2, 2017 Feb 23 2017
CTI BioPharma to Present at the BIO CEO & Investor Conference Feb 08 2017
CTI BioPharma Appoints Leading BioPharma Executive Michael Metzger To Board Of Directors Jan 24 2017
Latest Reports on Recent Market Movers: 3D Systems and CTI BioPharma Jan 10 2017
CTI BioPharma Announces Progress Of Lead Programs And Strategic Objectives For 2017 Jan 09 2017
CTI Biopharma stock revived after FDA ruling, reverse stock split Jan 06 2017
Why CTI BioPharma Corp. Stock Popped Today Jan 05 2017
CTI BioPharma Announces Removal Of Full Clinical Hold On Pacritinib Jan 05 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)